711 related articles for article (PubMed ID: 16819330)
1. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
2. A study of indefinite for dysplasia in Barrett's oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (alpha-methylacyl-CoA-racemase).
Sonwalkar SA; Rotimi O; Scott N; Verghese E; Dixon M; Axon AT; Everett SM
Histopathology; 2010 Jun; 56(7):900-7. PubMed ID: 20636793
[TBL] [Abstract][Full Text] [Related]
3. Expression of alpha-methylacyl-coenzyme A racemase in dysplastic Barrett's epithelium.
Lisovsky M; Falkowski O; Bhuiya T
Hum Pathol; 2006 Dec; 37(12):1601-6. PubMed ID: 16996568
[TBL] [Abstract][Full Text] [Related]
4. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.
Skacel M; Petras RE; Gramlich TL; Sigel JE; Richter JE; Goldblum JR
Am J Gastroenterol; 2000 Dec; 95(12):3383-7. PubMed ID: 11151865
[TBL] [Abstract][Full Text] [Related]
5. Alpha-methylacyl-CoA-racemase expression in adenocarcinoma, dysplasia and non-neoplastic epithelium of the stomach.
Lee WA
Oncology; 2006; 71(3-4):246-50. PubMed ID: 17652945
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.
Morris CD; Armstrong GR; Bigley G; Green H; Attwood SE
Am J Gastroenterol; 2001 Apr; 96(4):990-6. PubMed ID: 11316217
[TBL] [Abstract][Full Text] [Related]
7. Value of α-methylacyl-CoA racemase immunochemistry for predicting neoplastic progression in Barrett's oesophagus.
Kastelein F; Biermann K; Steyerberg EW; Verheij J; Kalisvaart M; Looijenga LH; Stoop HA; Walter L; Kuipers EJ; Spaander MC; Bruno MJ;
Histopathology; 2013 Nov; 63(5):630-9. PubMed ID: 24004067
[TBL] [Abstract][Full Text] [Related]
8. Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up.
Montgomery E; Bronner MP; Greenson JK; Haber MM; Hart J; Lamps LW; Lauwers GY; Lazenby AJ; Lewin DN; Robert ME; Washington K; Goldblum JR
Am J Gastroenterol; 2002 Jan; 97(1):27-31. PubMed ID: 11808966
[TBL] [Abstract][Full Text] [Related]
9. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.
Montgomery E; Goldblum JR; Greenson JK; Haber MM; Lamps LW; Lauwers GY; Lazenby AJ; Lewin DN; Robert ME; Washington K; Zahurak ML; Hart J
Hum Pathol; 2001 Apr; 32(4):379-88. PubMed ID: 11331954
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
B Brahim E; Mrabet A; Jouini R; Koubaa W; B Sidhom R; Elloumi H; Chadli A
Arab J Gastroenterol; 2016 Sep; 17(3):121-126. PubMed ID: 27567189
[TBL] [Abstract][Full Text] [Related]
11. Expression of alpha-methylacyl coenzyme A racemase in the dysplasia carcinoma sequence associated with Barrett's esophagus.
Scheil-Bertram S; Lorenz D; Ell C; Sheremet E; Fisseler-Eckhoff A
Mod Pathol; 2008 Aug; 21(8):961-7. PubMed ID: 18500268
[TBL] [Abstract][Full Text] [Related]
12. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
13. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
Glickman JN; Blount PL; Sanchez CA; Cowan DS; Wongsurawat VJ; Reid BJ; Odze RD
Hum Pathol; 2006 Oct; 37(10):1304-15. PubMed ID: 16949933
[TBL] [Abstract][Full Text] [Related]
14. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.
Srivastava A; Hornick JL; Li X; Blount PL; Sanchez CA; Cowan DS; Ayub K; Maley CC; Reid BJ; Odze RD
Am J Gastroenterol; 2007 Mar; 102(3):483-93; quiz 694. PubMed ID: 17338734
[TBL] [Abstract][Full Text] [Related]
15. Alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry in Barrett's and colorectal mucosa: only significant overexpression favours a diagnosis of intraepithelial neoplasia.
Sträter J; Wiesmüller C; Perner S; Kuefer R; Möller P
Histopathology; 2008 Feb; 52(3):399-402. PubMed ID: 18081815
[No Abstract] [Full Text] [Related]
16. p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression.
Skacel M; Petras RE; Rybicki LA; Gramlich TL; Richter JE; Falk GW; Goldblum JR
Am J Gastroenterol; 2002 Oct; 97(10):2508-13. PubMed ID: 12385431
[TBL] [Abstract][Full Text] [Related]
17. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
18. IMP3 Immunoreactivity is More Sensitive Than AMACR in Detecting Dysplastic Epithelium and Early Adenocarcinoma in Barrett Esophagus.
Gadara MR; Gonzalez M; Cartun RW; Ligato S
Appl Immunohistochem Mol Morphol; 2017 Jul; 25(6):386-391. PubMed ID: 26766126
[TBL] [Abstract][Full Text] [Related]
19. Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease.
Marx A; Wandrey T; Simon P; Wewer A; Grob T; Reichelt U; Minner S; Simon R; Spehlmann M; Tigges W; Soehendra N; Seitz U; Seewald S; Izbicki JR; Yekebas E; Kaifi JT; Mirlacher M; Terracciano L; Fleischmann A; Raedler A; Sauter G
Hum Pathol; 2009 Feb; 40(2):166-73. PubMed ID: 18835622
[TBL] [Abstract][Full Text] [Related]
20. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.
Sharma P; Falk GW; Weston AP; Reker D; Johnston M; Sampliner RE
Clin Gastroenterol Hepatol; 2006 May; 4(5):566-72. PubMed ID: 16630761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
